Executive Summary

The All Wales Medicines Strategy Group (AWMSG) is the HTA body for Wales. In many cases, the AWMSG do not need to carry out an appraisal, for example if NICE in England has already conducted a Single Technology Appraisal, but they are equipped to put products through full appraisals when needed. This page explains the different rules around submission to AWMSG, their appraisal processes, and how they differ from the rest of the UK, for example on orphan drugs.